Published in Sci Am on November 01, 1998
Natural selection and the elusiveness of happiness. Philos Trans R Soc Lond B Biol Sci (2004) 1.58
Exercise and gene expression: physiological regulation of the human genome through physical activity. J Physiol (2002) 1.21
Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibility. Evol Med Public Health (2014) 0.84
Alzheimer's disease and natural cognitive aging may represent adaptive metabolism reduction programs. Behav Brain Funct (2009) 0.82
Viral resistance evolution fully escapes a rationally designed lethal inhibitor. Mol Biol Evol (2009) 0.78
Pain as an evolutionary necessity. Neurol Sci (2011) 0.76
A novel evolution-based method for detecting gene-gene interactions. PLoS One (2011) 0.76
Power and Autistic Traits. Front Psychol (2016) 0.75
Veterinary medicine for a world in crisis. Can Vet J (2007) 0.75
Health care - an everlasting challenge in temporal and spatial domains. J Multidiscip Healthc (2010) 0.75
Behaviour Centred Design: towards an applied science of behaviour change. Health Psychol Rev (2016) 0.75
A Philosophical Perspective on Evolutionary Systems Biology. Biol Theory (2015) 0.75
Why reproduce sexually? J Theor Biol (1973) 2.77
The question of adaptive sex ratio in outcrossed vertebrates. Proc R Soc Lond B Biol Sci (1979) 2.74
Why do physicians vary so widely in their referral rates? J Gen Intern Med (2000) 2.43
The dawn of Darwinian medicine. Q Rev Biol (1991) 2.35
Emergency Methods for Rhesus Group Determination. J Clin Pathol (1951) 2.23
Risk aversion and costs: a comparison of family physicians and general internists. J Fam Pract (2000) 1.67
Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses. Biol Psychiatry (1994) 1.53
Marital quality and psychological adjustment to widowhood among older adults: a longitudinal analysis. J Gerontol B Psychol Sci Soc Sci (2000) 1.51
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release (2003) 1.31
Childhood adversity and vulnerability to mood and anxiety disorders. Depress Anxiety (1997) 1.27
Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry (2001) 1.11
The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis. J Clin Invest (1975) 1.11
Defects of bile acid synthesis in Zellweger's syndrome. Science (1979) 1.10
Pretreatment nausea in cancer chemotherapy: a conditioned response? Psychosom Med (1980) 1.08
Assessing microbial contamination in clean water dental units and compliance with disinfection protocol. J Am Dent Assoc (1994) 1.07
Adrenergic function in patients with panic anxiety. Arch Gen Psychiatry (1984) 1.01
Metabolism of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 26-tetrol and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25-tetrol into cholic acid in normal human subjects. J Lipid Res (1979) 1.00
Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosom Med (1996) 0.96
Eye height scaling of absolute size in immersive and nonimmersive displays. J Exp Psychol Hum Percept Perform (2000) 0.92
Milolides, new briarane diterpenoids from the western Pacific octocoral Briareum stechei. J Nat Prod (2001) 0.91
Ages of onset of DSM-III anxiety disorders. Compr Psychiatry (1985) 0.91
The effect of plasma cortisol levels on the lymphocyte transformation test. J Allergy Clin Immunol (1972) 0.90
Effect of alcohol on social phobic anxiety. Am J Psychiatry (1999) 0.90
Peripheral catecholamine levels and the symptoms of anxiety: studies in patients with and without pheochromocytoma. Psychosom Med (1990) 0.90
The nutrient-toxin dosage continuum in human evolution and modern health. Q Rev Biol (1999) 0.90
The relationship between discrimination and articulation training in children with misarticulations. J Speech Hear Res (1975) 0.89
Hepatic extraction of bile salts in conscious dogs. Am J Physiol (1979) 0.87
Cholecystokinin-4 and panic. Arch Gen Psychiatry (1990) 0.86
Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry (1994) 0.85
Alcohol abuse among clinically anxious patients. Behav Res Ther (1986) 0.84
Endocrine and cardiovascular responses during phobic anxiety. Psychosom Med (1985) 0.83
Detection of red reflex asymmetry by pediatric residents using the Brückner reflex versus the MTI photoscreener. Pediatrics (2001) 0.83
A comparison of panic disorder and agoraphobia with panic attacks. Compr Psychiatry (1985) 0.83
Defense mechanism changes in successfully treated patients with obsessive-compulsive disorder. Am J Psychiatry (1998) 0.82
Group behavioral therapy of obsessive-compulsive disorder: seven vs. twelve-week outcomes. Depress Anxiety (2001) 0.82
Anxiety and cardiovascular reactivity in the Tecumseh population. J Hypertens (1998) 0.82
Bile acid formation in man: metabolism of 7 -hydroxy-4-cholesten-3-one in bile fistula patients. J Lipid Res (1973) 0.81
Sex and evolution. Monogr Popul Biol (1975) 0.81
Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model. Psychoneuroendocrinology (1996) 0.81
Micellar properties of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestan-26-oyl taurine and relationship to in vitro red cell disruption. J Lab Clin Med (1979) 0.81
A standardized behavioral group treatment program for obsessive-compulsive disorder: preliminary outcomes. Behav Res Ther (1991) 0.80
Metabolism of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oic acid in normal subjects with an intact enterohepatic circulation. J Lipid Res (1977) 0.80
Systemic hormonal and physiological abnormalities in anxiety disorders. Psychoneuroendocrinology (1988) 0.80
Articulatory-defective children's discrimination of their production errors. J Speech Hear Disord (1975) 0.80
Evidence for carrier proteins in bile acid synthesis. The effect of squalene and sterol carrier protein and albumin on the activity of 12alpha-hydroxylase. Biochim Biophys Acta (1976) 0.80
Urinary catecholamines and mitral valve prolapse in panic-anxiety patients. Psychiatry Res (1985) 0.80
The relationship of medical problems and medications to treatment of the denture patient. Gerodontics (1986) 0.79
Effective use of nisin to control lactic acid bacterial spoilage in vacuum-packed bologna-type sausage. J Food Prot (1999) 0.79
Formation of cholic acid via 3 alpha, 7 alpha,12 alpha-trihydroxy-5 beta-cholestan-26-oic acid in the dog. Biochim Biophys Acta (1979) 0.78
Case histories and shorter communications. Agoraphobia: a test of the separation anxiety hypothesis. Behav Res Ther (1985) 0.78
Anxiety induced by flooding therapy for phobias does not elicit prolactin secretory response. Psychosom Med (1980) 0.78
The metabolism of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oic acid into cholic: an enzyme assay using homogenates of human liver. J Lipid Res (1976) 0.77
Stereochemistry of the side chain oxidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha-triol in man. J Biol Chem (1980) 0.77
Formation of bile acids in man. Metabolism of 7alpha-hydroxy-4-cholesten-3-one in normal subjects with an intact enterohepatic circulation. Biochim Biophys Acta (1976) 0.77
Patients with alcohol problems in primary care: understanding their resistance and motivating change. Prim Care (1999) 0.77
An evolutionary perspective on psychiatry. Compr Psychiatry (1985) 0.77
Platelet alpha 2-adrenoreceptors, catecholamines, hemodynamic variables, and anxiety in panic patients and their asymptomatic relatives. Psychosom Med (1996) 0.76
Treatment of panic-like attacks with a long-acting analogue of somatostatin. J Clin Psychopharmacol (1990) 0.76
Anxiety in patients with pheochromocytomas. Arch Intern Med (1985) 0.76
Evolutionary biology: a basic science for psychiatry? Acta Psychiatr Scand (1992) 0.76
Hepatic lesions and hemolysis following administration of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oyl taurine to rats. J Lab Clin Med (1977) 0.75
Phobic anxiety does not affect plasma levels of thyroid stimulating hormone in man. Psychoneuroendocrinology (1982) 0.75
Competitive inhibition of side chain oxidation of 3 alpha, 7 alpha-dihydroxy-5 beta-cholestan-26-oic acid by 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestan-26-oic acid in the hamster. J Lipid Res (1980) 0.75
Symptom profiles of patients with DSM-III anxiety disorders. Am J Psychiatry (1986) 0.75
On the modelling of sexual selection. Q Rev Biol (1981) 0.75
Panic disorder: a test of the separation anxiety hypothesis. Behav Res Ther (1986) 0.75
Psychobiology of anxiety and anxiety disorders. Psychiatr Clin North Am (1985) 0.75
Pseudohallucinations in cancer chemotherapy patients. Am J Psychiatry (1983) 0.75
Reduction of 2,3,5-tri-O-benzyl-alpha (and beta)-D-ribofuranosylethyne. Carbohydr Res (1975) 0.75
Effect of taurocholate on the conversion of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oic acid into cholic acid. Steroids (1978) 0.75
The synthesis of D-ribofuranosyl derivatives of methyl propiolate and a study of the activating influence of the ester group in cycloaddition reactions. Carbohydr Res (1977) 0.75
Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety. Arch Gen Psychiatry (1984) 0.75
Oral health and aging. Dentistry (1989) 0.75
Stimulation of corticotropin release by pentagastrin in normal subjects and patients with panic disorder. Biol Psychiatry (1991) 0.75
C-nucleoside studies. Part 6. Synthesis of 3-[2,3,5-tri-O-benzyl-beta-(and alpha)-D-ribofuranosyl]prop-2-yn-1-ol and related compounds; a new synthesis of 3(5)-(2,3,5-tri-O-benzyl-beta-D-ribofuranosyl)pyrazole. J Chem Soc Perkin 1 (1977) 0.75
Aging in America: implications for dentistry. J Md State Dent Assoc (1987) 0.75
How antipanic drugs might work. Am J Psychiatry (1986) 0.75
The effect of nisin on the keeping quality of reduced heat-treated milks. J Food Prot (2001) 0.75
Health maintenance issues of the elderly. Oral health. Md Med J (1989) 0.75
Immunodeficiency, xanthomas and obstructive liver disease. Am J Med (1976) 0.75
The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry (1982) 0.75